Penumbra Inc (NYSE:PEN)
$ 186.94 -13.07 (-6.53%) Market Cap: 7.26 Bil Enterprise Value: 7.66 Bil PE Ratio: 549.82 PB Ratio: 6.25 GF Score: 82/100

Penumbra Inc at Jefferies London Healthcare Conference Transcript

Nov 15, 2022 / 09:10AM GMT
Release Date Price: $195.99 (+1.30%)
Michael Anthony Sarcone
Jefferies LLC, Research Division - Equity Analyst

Good morning, and welcome to day 1 of the Jefferies 2022 London Healthcare Conference. My name is Michael Sarcone. I'm an analyst on the U.S. Medical Supplies and Devices team. And with us today, we're happy to have Penumbra, and we have Adam Elsesser, Co-Founder, Chairman and CEO. So Adam, thanks for joining us today.

Adam Elsesser
Penumbra, Inc. - Co-Founder, Chairman, President & CEO

My pleasure.

Questions & Answers

Michael Anthony Sarcone
Jefferies LLC, Research Division - Equity Analyst

Great. So just to kick it off. It's a really exciting time for Penumbra. You've talked about 2023 as being one of the most exciting years in the company's history. I was hoping you could just take some time and kick off why that is and just give us an overview.

Adam Elsesser
Penumbra, Inc. - Co-Founder, Chairman, President & CEO

Yes. No, thank you. Again, thank you for having us. 2023 is

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot